Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

NCT00835055 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-04-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Conditions

Sponsors & Collaborators

  • St. Claraspital AG

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2019-04-01
Completion
2019-04-01

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00835055 on ClinicalTrials.gov